Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
A Phase 3 Randomized, Rater-Blinded Study Comparing Two Annnual Cycles of Intravenous Alemtuzumab to Three-Times Weekly Subcutaneous Interferon Beta-1a (Rebif) in Treatment-Naive Patients with Relapsing Multiple Sclerosis
Houff, Sidney
(PI)
Neurology
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
4/4/08
→
12/31/09
View all
View less